The Real-World Data Impact Award (RWIA) supports the American Cancer Society’s and Flatiron Health’s goals of accelerating cancer research that has strong potential to inform public health, public policy or to improve clinical practice and contribute to health equity.
Novel research utilizing existing Flatiron Health, Inc. (FHI) cancer patient data to explore areas that may lead to improvements in US public health, public policy, and quality of cancer care.
FHI curates information from electronic health records, with 22 disease-specific data sets available for research under the award mechanism. Examples of research topics within scope of the award are provide below. This list is not comprehensive. We encourage applicants to review published research utilizing FHI data (https://flatiron.com/publications/):
Interactive Webinar to Learn More: Oct. 31, 2022 4 PM ET
Interested grantees can hear an overview of this funding opportunity and FHI’s datasets. There will be ample time to ask questions.
Register for the Zoom meeting Webinar will be recorded and available upon request.
Signed Non-disclosure Agreement Due: Mon., Nov. 7, 2022
LOI Due Date: Weds., Nov. 30, 2022 at 11:59 PM ET
Invitation-to-Apply Date: Feb. 2023
Application Deadline (if invited):
April 3, 2023
Application Peer Review: June 2023
Award Notification: September 2023
Grant Activation: Jan. 2024
Applicants should review the American Cancer Society RWIA Grant Policies and Instructions.
Questions? Please contact Kimberly.Clarke@cancer.org
See these press releases about projects previously funded under this RFA
Grants funded in 2022 – coming soon
This award mechanism is for American Cancer Society (ACS) current and former grantees conducting health services, health policy research, or public health research using real-world data. Applicants meeting the below criteria will be invited to apply for this RFA via proposalCENTRAL.
Note: Current and former RWIA grantees are not eligible to apply.
Applications may be submitted by a college, university, medical school, or other not-for-profit research organization within the United States, its territories, and the Commonwealth of Puerto Rico.
All applicants shall be subject to the terms and conditions of a separate confidentiality agreement between Flatiron and the Grantee.
Grant Term and Budget: $75,000 direct cost for a 1-year award period; no indirect costs are allowed.
Eligible current and former grantees will be informed of the grant opportunity and will automatically be invited to the first step in the process (i.e., the pre-LOI). Investigators interested in applying need to sign a confidentiality agreement with Flatiron Health in proposalCENTRAL (denoted as “Pre-LOI”) and then submit a letter of intent (LOI).
Pre-LOI: FHI Nondisclosure Confidentiality Agreement
Letter of Intent (LOI)
LOI Review Process: A two-phased process will be used to determine which investigators will be invited to submit supplemental award proposals. Applicants will receive the FHI assessment and the reviewers’ critiques.
Full Applications: ·
Funds Available for Awards: Funds will support up to 3 Real-World Data Impact awards. Awarded institutions will contract with ACS using their individual Terms and Conditions. All awardees will be required to comply with the terms and conditions in the FHI nondisclosure confidentiality agreement and the FHI data use agreement, which outlines the terms and conditions required for the Grantee’s use, receipt, and storage of FHI licensed data.
Goes to proposalCENTRAL